Sep 30, 2026 08:31AM

Sep 30, 2026 08:30AM

Sep 25, 2026 08:30AM

Sep 24, 2026 08:30AM

Sep 24, 2026 08:30AM

Aug 5, 2026 04:05PM

Jul 27, 2026 08:30AM Sarepta Therapeutics names Michael Severino as new CEO

Jul 27, 2026 08:30AM

Jul 1, 2026 06:58AM

Jun 30, 2026 11:00AM

Jun 30, 2026 08:30AM

Jun 30, 2026 08:30AM

Jun 3, 2026 08:30AM

May 6, 2026 04:05PM Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments

Mar 25, 2026 08:05AM

Mar 25, 2026 08:05AM

Mar 19, 2026 11:11AM

Mar 19, 2026 10:57AM

Mar 19, 2026 08:30AM

Mar 19, 2026 08:30AM

Mar 16, 2026 08:34AM Sarepta begins enrollment for enhanced safety protocol in gene therapy study

Mar 16, 2026 08:33AM

Mar 12, 2026 05:06PM

Mar 9, 2026 03:22PM

Mar 3, 2026 12:00PM

Feb 25, 2026 04:05PM

Feb 24, 2026 09:08AM

Feb 24, 2026 09:07AM Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan

Jan 26, 2026 08:01AM

Jan 26, 2026 08:00AM

Jan 12, 2026 11:59AM

Jan 12, 2026 11:58AM

Jan 12, 2026 09:30AM

Dec 9, 2025 06:50AM

Nov 25, 2025 08:58AM Sarepta receives FDA approval for ELEVIDYS study with enhanced immunosuppression

Nov 25, 2025 08:57AM

Nov 24, 2025 07:31AM

Nov 24, 2025 07:30AM

Nov 20, 2025 03:59AM

Nov 14, 2025 02:59PM

Nov 14, 2025 02:54PM

Nov 14, 2025 02:02PM FDA approves new safety warning and revised indication that limits use for Elevidys following reports of fatal liver injuryHHS: FDA approves new safety warning and revised indication that limits

Nov 3, 2025 04:13PM

Nov 3, 2025 04:05PM

Oct 3, 2025 08:30AM

Aug 13, 2025 04:13PM

Aug 13, 2025 04:12PM

Aug 12, 2025 01:25PM

Aug 11, 2025 01:59PM Jefferies Reiterates Buy Rating on Sarepta Therapeutics (SRPT)

Aug 6, 2025 04:05PM

332,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All